Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Rebecca Bowen"'
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 51, Iss 1, Pp 618-629 (2023)
AbstractGynaecological cancers are a major global health concern due to the lack of effective screening programmes for ovarian and endometrial cancer, for example, and variable access to vaccination and screening tests for cervical cancer in many cou
Externí odkaz:
https://doaj.org/article/058e7bf68a1648fb968de25df78c1ed6
Autor:
Amit Bahl, William Wilson, Jessica Ball, Emily Renninson, Sidharth Dubey, Alicia Bravo, Emily Foulstone, Saiqa Spensley, Rebecca Bowen, Janine Mansi, Simon Waters, Pippa Riddle, Duncan Wheatley, Peter Stephens, Pavel Bezecny, Srinivasan Madhusudan, Mark Verrill, Jeremy Braybrooke, Charles Comins, Vivek Mohan, Abigail Gee, Hannah Kirk, Alison Markham, Heidi Evans, Eve Watson, Mark Callaway, Sylvia Pearson, Allan Hackshaw, Mark Churn
Publikováno v:
Breast, Vol 66, Iss , Pp 69-76 (2022)
Background: Paclitaxel is commonly used as first-line chemotherapy for HER2-negative metastatic breast cancer (MBC) patients. However, with response rates of 21.5–53.7% and significant risk of peripheral neuropathy, there is need for better chemoth
Externí odkaz:
https://doaj.org/article/82333b9202654f2ab93e6857aabae51e
Autor:
Patricia Stoddard-Dare, Kelle K. DeBoth, Madalynn Wendland, Ryan Suder, Joan Niederriter, Rebecca Bowen, Sara Dugan, Miyuki Tedor
Publikováno v:
Advances in Social Work, Vol 20, Iss 2, Pp 216-235 (2020)
An interprofessional response is needed to mitigate the deleterious effects of the opioid epidemic. Here we describe an interprofessional workshop for n=307 students from social work, pharmacy, medicine, nursing, occupational therapy, physical therap
Externí odkaz:
https://doaj.org/article/09388b152aac464cba6d3d1853ee18a9
Autor:
Sudha Sundar, Andy Nordin, Jo Morrison, Nick Wood, Sadaf Ghaem-Maghami, Jo Nieto, Andrew Phillips, John Butler, Kevin Burton, Rob Gornall, Stephen Dobbs, Rosalind Glasspool, Richard Peevor, Jonathan Ledermann, Iain McNeish, Nithya Ratnavelu, Tim Duncan, Jonathan Frost, Kenneth Lim, Agnieszka Michael, Elly Brockbank, Ketankumar Gajjar, Alexandra Taylor, Rebecca Bowen, Adrian Andreou, Raji Ganesan, Shibani Nicum, Richard Edmondson, Richard Clayton, Janos Balega, Phil Rolland, Hilary Maxwell, Christina Fotopoulou
Publikováno v:
Cancers, Vol 15, Iss 2, p 337 (2023)
Ovarian cancer survival in the UK lags behind comparable countries. Results from the ongoing National Ovarian Cancer Audit feasibility pilot (OCAFP) show that approximately 1 in 4 women with advanced ovarian cancer (Stage 2, 3, 4 and unstaged cancer)
Externí odkaz:
https://doaj.org/article/8196ed148f974bed9f23c4079a7ed8d8
Autor:
Susana Banerjee, Holly Tovey, Rebecca Bowen, Elizabeth Folkerd, Lucy Kilburn, Jennifer McLachlan, Marcia Hall, Nina Tunariu, Ayoma Attygalle, Joao Paulo Da Silveira Nogueira Lima, Sophie Perry, Peter Chatfield, Margaret Hills, Stan Kaye, Gert Attard, Mitch Dowsett, Judith M. Bliss
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Recurrent epithelial ovarian cancer (EOC) remains difficult to treat, with an urgent need for more therapy options. Androgens bind to the androgen receptor (AR), commonly expressed in EOC. CYP17 inhibitor abiraterone irreversibly inhibits
Externí odkaz:
https://doaj.org/article/573e022757c443b698c2911c247d9712
Publikováno v:
Cancers, Vol 13, Iss 5, p 952 (2021)
Older women with ovarian cancer have disproportionately poorer survival outcomes than their younger counterparts and receive less treatment. In order to understand where the gaps lie in the treatment of older patients, studies incorporating more deta
Externí odkaz:
https://doaj.org/article/f9cc889b7a0d4594adbf90ed496c451d
Autor:
Rebecca Bowen
Publikováno v:
Italian Studies. 78:1-18
Autor:
Geoffrey J. Lindeman, Tharu M. Fernando, Rebecca Bowen, Katarzyna J. Jerzak, Xinni Song, Thomas Decker, Frances Boyle, Steve McCune, Anne Armstrong, Catherine Shannon, Gianfilippo Bertelli, Ching-Wei Chang, Rupal Desai, Kushagra Gupta, Timothy R. Wilson, Aulde Flechais, Aditya Bardia
Publikováno v:
Clinical Cancer Research. 28:3256-3267
Purpose: Despite promising activity in hematopoietic malignancies, efficacy of the B-cell lymphoma 2 (BCL2) inhibitor venetoclax in solid tumors is unknown. We report the prespecified VERONICA primary results, a randomized phase II clinical trial eva
Autor:
Aditya Bardia, Aulde Flechais, Timothy R. Wilson, Kushagra Gupta, Rupal Desai, Ching-Wei Chang, Gianfilippo Bertelli, Catherine Shannon, Anne Armstrong, Steve McCune, Frances Boyle, Thomas Decker, Xinni Song, Katarzyna J. Jerzak, Rebecca Bowen, Tharu M. Fernando, Geoffrey J. Lindeman
Supplementary Data from VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003d9ac655eca985a9fe7e9508e49303
https://doi.org/10.1158/1078-0432.22487561.v1
https://doi.org/10.1158/1078-0432.22487561.v1
Autor:
Aditya Bardia, Aulde Flechais, Timothy R. Wilson, Kushagra Gupta, Rupal Desai, Ching-Wei Chang, Gianfilippo Bertelli, Catherine Shannon, Anne Armstrong, Steve McCune, Frances Boyle, Thomas Decker, Xinni Song, Katarzyna J. Jerzak, Rebecca Bowen, Tharu M. Fernando, Geoffrey J. Lindeman
Purpose:Despite promising activity in hematopoietic malignancies, efficacy of the B-cell lymphoma 2 (BCL2) inhibitor venetoclax in solid tumors is unknown. We report the prespecified VERONICA primary results, a randomized phase II clinical trial eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe6794922eb626d9a58bb55c79dbfc5
https://doi.org/10.1158/1078-0432.c.6532544
https://doi.org/10.1158/1078-0432.c.6532544